Modafinil

CHEMBL1373 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
273.4 g/mol
LogP
1.7
Phase
4

This medication promotes wakefulness by influencing several neurotransmitter systems in the brain, though its exact mechanism is not fully understood. It is used to treat excessive sleepiness associated with narcolepsy, shift work disorder, and sleep apnea.

분자량

273.4000 g/mol

LogP

1.70

TPSA

79.40 Ų

리핀스키 5의 법칙

통과

치료 영역

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1

InChI

InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)

Molecular Formula

C15H15NO2S

HBD / HBA

1 / 3

회전 가능 결합

5

무거운 원자

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

This medication promotes wakefulness by influencing several neurotransmitter systems in the brain, though its exact mechanism is not fully understood. It is used to treat excessive sleepiness associated with narcolepsy, shift work disorder, and sleep apnea.

Yes, Modafinil is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1373. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4236. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.